| MeSH term | MeSH ID | Detail |
|---|---|---|
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Pedersen SH et al. | Medroxyprogesterone acetate attenuates long-term effects of 17beta-estradiol in coronary arteries from hyperlipidemic rabbits. | 2006 | Steroids | pmid:16815506 |
| Dean HJ and Winter JS | The effect of five synthetic progestational compounds on 5 alpha-reductase activity in genital skin fibroblast monolayers. | 1984 | Steroids | pmid:6523531 |
| Ambrus G et al. | Microbiological 1 alpha-hydroxylation of norethisterone. | 1975 | Steroids | pmid:1167432 |
| Wan AS et al. | Long-acting contraceptive agents: norethisterone esters of arylcarboxylic acids. | 1983 | Steroids | pmid:6658878 |
| Wan AS et al. | Long-acting contraceptive agents: furylalkylcarboxylic acid esters of norethisterone. | 1983 | Steroids | pmid:6658879 |
| Tasić L et al. | [Comparison of two different types of hormone therapy effects on haemostatic parameters in early postmenopausal women]. | 2011 Jan-Feb | Srp Arh Celok Lek | pmid:21568083 |
| HUTCHERSON WP et al. | NORETHINDRONE WITH ESTROGEN AS AN ORAL CONTRACEPTIVE: A PRELIMINARY REPORT. | 1963 | South. Med. J. | pmid:14103116 |
| Holt R | Laparoscopic removal of an intrauterine contraceptive device in an oral contraceptive user. | 1973 | South. Med. J. | pmid:4270142 |
| Barranco VP and Jones DD | Effect of oral contraceptives on acne. | 1974 | South. Med. J. | pmid:4275275 |
| McFarland HR | Regression of cerebral lesions after cessation of oral contraceptives. | 1970 | South. Med. J. | pmid:5411921 |
| McGee RR | Hormone therapy for gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. | 1995 | South. Med. J. | pmid:7481972 |
| Wardekar AS et al. | Myocardial infarction and oral contraceptives. | 1973 | South. Med. J. | pmid:4691020 |
| Greenberg HB | Pulmonary infarction following the use of an oral contraceptive: in a women of blood group A. | 1971 | South. Med. J. | pmid:5573074 |
| Board JA | Contraception with norethindrone 0.35 mg administered continuously. | 1976 | South. Med. J. | pmid:1246653 |
| Semmer JR and Diddle AW | Oral contraceptive medication and glucose metabolism: long-term treatment. | 1974 | South. Med. J. | pmid:4597914 |
| Kane FJ | Psychosis associated with the use of oral contraceptive agents. | 1969 | South. Med. J. | pmid:4179717 |
| Nesbit RR and Deweese JA | Mesenteric venous thrombosis and oral contraceptives. | 1977 | South. Med. J. | pmid:847490 |
| Board JA et al. | Spironolactone and estrogen-progestin therapy for hirsutism. | 1987 | South. Med. J. | pmid:3563583 |
| Smit J et al. | Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa. | 2002 | Soc Sci Med | pmid:12297238 |
| Morris NM and Udry JR | Sexual frequency and contraceptive pills. | 1971 | Soc Biol | pmid:4931720 |